GOSSAMER BIO INC (GOSS) Stock News

NASDAQ:GOSS - Nasdaq - US38341P1021 - Common Stock - Currency: USD

1.97 +0.04 (+2.07%)

After market: 2 +0.03 (+1.52%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

GOSS Latest News, Press Relases and Analysis

All

Press Releases

6 days ago - By: Gossamer Bio, Inc.

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

8 days ago - By: Zacks Investment Research - Mentions: VSTM

Gossamer Bio (GOSS) Reports Q2 Loss, Beats Revenue Estimates

8 days ago - By: Gossamer Bio, Inc.

Gossamer Bio Announces Second Quarter 2025 Financial Results and Provides Business Update

3 months ago - By: Benzinga

Exploring Gossamer Bio's Earnings Expectations

a year ago - By: BusinessInsider

News Image

GOSS Stock Earnings: Gossamer Bio Misses EPS, Misses Revenue for Q2 2024

8 days ago - By: Zacks Investment Research - Mentions: HRMY

Harmony Biosciences Holdings, Inc. (HRMY) Misses Q2 Earnings and Revenue Estimates

a month ago - By: Benzinga - Mentions: CVM AAPL GILT RARE ...

Ultragenyx Pharmaceutical, Apple And Other Big Stocks Moving Lower In Monday's Pre-Market Session

2 months ago - By: Gossamer Bio, Inc.

Gossamer Bio Announces Completion of Enrollment in Registrational Phase 3 PROSERA Study for the Treatment of PAH

2 months ago - By: Gossamer Bio, Inc.

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

3 months ago - By: Zacks Investment Research - Mentions: ROIV

Gossamer Bio (GOSS) Reports Q1 Loss, Tops Revenue Estimates

3 months ago - By: Gossamer Bio, Inc.

Gossamer Bio Announces First Quarter 2025 Financial Results and Provides Business Update, Including Closure of New Patient Screening in Phase 3 PROSERA Study

3 months ago - By: Yahoo Finance - Mentions: PYPL

FTA to defend open banking in court

3 months ago - By: Gossamer Bio, Inc.

Gossamer Bio to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 15, 2025

3 months ago - By: Gossamer Bio, Inc.

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

3 months ago - By: Gossamer Bio, Inc.

Gossamer Bio to Present Preclinical Data at the American Thoracic Society (ATS) 2025 International Conference

4 months ago - By: Yahoo Finance - Mentions: DB BTU EQH NVDA ...

Peabody pauses seeking debt for partial refinance of $2.1bn private loan

4 months ago - By: Yahoo Finance - Mentions: GERN CAN GILD NUVB ...

Is Geron Corp. (NASDAQ:GERN) the Best Biotech Penny Stock to Buy According to Hedge Funds?

4 months ago - By: Yahoo Finance - Mentions: ECX CAN AIG PLTR ...

Is Ecarx Holdings Inc. (NASDAQ:ECX) the Best Penny Stock to Invest in Under $1?

4 months ago - By: Yahoo Finance - Mentions: ALSN CAN NUVB BTU ...

Is Gossamer Bio Inc. (NASDAQ:GOSS) the Best Penny Stock to Invest in Under $1?

4 months ago - By: Yahoo Finance - Mentions: COIN AMD DG NVDA ...

Coinbase price target lowered to $275 from $390 at Monness Crespi

4 months ago - By: Yahoo Finance - Mentions: RLAY KIND DAWN BG ...

Relay Therapeutics, Inc. (RLAY): Among Stocks Under $10 that Will Triple

4 months ago - By: Yahoo Finance - Mentions: PRLD DAWN VIR NUVB ...

Gossamer Bio, Inc. (GOSS): Among Stocks Under $10 that Will Triple

4 months ago - By: Yahoo Finance - Mentions: NUVB RLAY TSLA DAWN ...

Nuvation Bio Inc. (NUVB): Among Stocks Under $10 that Will Triple

4 months ago - By: Yahoo Finance - Mentions: NTLA NUVB IBRX VSAT ...

Intellia Therapeutics, Inc. (NTLA): Among Stocks Under $10 that Will Triple

4 months ago - By: Yahoo Finance - Mentions: PLTR COMP MRVL AJG ...

1 Artificial Intelligence (AI) Growth Stock That Could Soar Thanks to Trump's Tariffs

4 months ago - By: Gossamer Bio, Inc.

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

5 months ago - By: Gossamer Bio, Inc.

Gossamer Bio Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

5 months ago - By: Gossamer Bio, Inc.

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

6 months ago - By: Gossamer Bio, Inc.

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

6 months ago - By: Gossamer Bio, Inc.

Gossamer Bio Presented Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress

7 months ago - By: Gossamer Bio, Inc.

Gossamer Bio to Present Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress

7 months ago - By: Gossamer Bio, Inc.

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

9 months ago - By: Gossamer Bio, Inc.

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

9 months ago - By: Gossamer Bio, Inc.

Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update

10 months ago - By: Gossamer Bio, Inc.

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

a year ago - By: Gossamer Bio, Inc.

Gossamer Bio Announces Data Presentations at the European Respiratory Society Congress 2024